分子診断&治療の世界市場:規模・現状・予測2019-2025

QYResearchが発行した調査報告書(QYR20FB14178)
◆英語タイトル:Global Molecular Diagnosis and Therapy Market Size, Status and Forecast 2019-2025
◆商品コード:QYR20FB14178
◆発行会社(リサーチ会社):QYResearch
◆発行日:2019年11月25日
◆ページ数:99
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療・製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥526,500見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥789,750見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,053,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

※当調査レポートでは、分子診断&治療の世界市場について調査・分析し、分子診断&治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別(PCR、DNAシーケンス、NGS)、用途別(診断研究所、研究研究所)、地域別(北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米)に区分して市場規模を算出しました。


・レポートの概要
・世界の分子診断&治療市場動向
・主要企業別マーケットシェア
・分子診断&治療の種類別市場規模2014-2019
(PCR、DNAシーケンス、NGS)
・分子診断&治療の用途別市場規模2014-2019
(診断研究所、研究研究所)
・分子診断&治療の北米市場:主要企業・種類別/用途別市場規模
・分子診断&治療のヨーロッパ市場:主要企業・種類別/用途別市場規模
・分子診断&治療の中国市場:主要企業・種類別/用途別市場規模
・分子診断&治療の日本国内市場:主要企業・種類別/用途別市場規模
・分子診断&治療の東南アジア市場:主要企業・種類別/用途別市場規模
・分子診断&治療のインド市場:主要企業・種類別/用途別市場規模
・分子診断&治療の中南米市場:主要企業・種類別/用途別市場規模
・主要企業のプロフィール
(Abbott Laboratories、Agilent Technologies、Becton, Dickinson and Company、Biomérieux Sa、Danaher Corporation、Diasorin、Grifols、Hologic、Illumina、Qiagen、Roche Diagnostics、Siemens AG、Thermo Fisher Scientific)
・分子診断&治療の市場規模予測2019-2025
(種類別、用途別、地域別市場予測)
・アナリストの観点・結論
...
【レポートの概要】

Molecular Diagnosis & Therapy provides researchers and healthcare professionals with insights into the latest molecular diagnostic and therapeutic techniques and their use in precision medicine.In 2018, the global Molecular Diagnosis and Therapy market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Molecular Diagnosis and Therapy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Molecular Diagnosis and Therapy development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
Abbott Laboratories
Agilent Technologies
Becton, Dickinson and Company
Biomérieux Sa
Danaher Corporation
Diasorin
Grifols
Hologic
Illumina
Qiagen
Roche Diagnostics
Siemens AG
Thermo Fisher Scientific

Market segment by Type, the product can be split into
PCR
DNA Sequencing
NGS

Market segment by Application, split into
Diagnostic Laboratories
Research & Academic Laboratories

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Molecular Diagnosis and Therapy status, future forecast, growth opportunity, key market and key players.
To present the Molecular Diagnosis and Therapy development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Molecular Diagnosis and Therapy are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Molecular Diagnosis and Therapy Market Size Growth Rate by Type (2014-2025)
1.4.2 PCR
1.4.3 DNA Sequencing
1.4.4 NGS
1.5 Market by Application
1.5.1 Global Molecular Diagnosis and Therapy Market Share by Application (2019-2025)
1.5.2 Diagnostic Laboratories
1.5.3 Research & Academic Laboratories
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Molecular Diagnosis and Therapy Market Size
2.2 Molecular Diagnosis and Therapy Growth Trends by Regions
2.2.1 Molecular Diagnosis and Therapy Market Size by Regions (2019-2025)
2.2.2 Molecular Diagnosis and Therapy Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis

3 Market Share by Key Players
3.1 Molecular Diagnosis and Therapy Market Size by by Players
3.1.1 Global Molecular Diagnosis and Therapy Revenue by by Players (2014-2019)
3.1.2 Global Molecular Diagnosis and Therapy Revenue Market Share by by Players (2014-2019)
3.1.3 Global Molecular Diagnosis and Therapy Market Concentration Ratio (CR5 and HHI)
3.2 Molecular Diagnosis and Therapy Key Players Head office and Area Served
3.3 Key Players Molecular Diagnosis and Therapy Product/Solution/Service
3.4 Date of Enter into Molecular Diagnosis and Therapy Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Molecular Diagnosis and Therapy Market Size by Type (2014-2019)
4.2 Global Molecular Diagnosis and Therapy Market Size by Application (2014-2019)

5 North America
5.1 North America Molecular Diagnosis and Therapy Market Size (2014-2019)
5.2 Molecular Diagnosis and Therapy Key Players in North America
5.3 North America Molecular Diagnosis and Therapy Market Size by Type
5.4 North America Molecular Diagnosis and Therapy Market Size by Application

6 Europe
6.1 Europe Molecular Diagnosis and Therapy Market Size (2014-2019)
6.2 Molecular Diagnosis and Therapy Key Players in Europe
6.3 Europe Molecular Diagnosis and Therapy Market Size by Type
6.4 Europe Molecular Diagnosis and Therapy Market Size by Application

7 China
7.1 China Molecular Diagnosis and Therapy Market Size (2014-2019)
7.2 Molecular Diagnosis and Therapy Key Players in China
7.3 China Molecular Diagnosis and Therapy Market Size by Type
7.4 China Molecular Diagnosis and Therapy Market Size by Application

8 Japan
8.1 Japan Molecular Diagnosis and Therapy Market Size (2014-2019)
8.2 Molecular Diagnosis and Therapy Key Players in Japan
8.3 Japan Molecular Diagnosis and Therapy Market Size by Type
8.4 Japan Molecular Diagnosis and Therapy Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Molecular Diagnosis and Therapy Market Size (2014-2019)
9.2 Molecular Diagnosis and Therapy Key Players in Southeast Asia
9.3 Southeast Asia Molecular Diagnosis and Therapy Market Size by Type
9.4 Southeast Asia Molecular Diagnosis and Therapy Market Size by Application

10 India
10.1 India Molecular Diagnosis and Therapy Market Size (2014-2019)
10.2 Molecular Diagnosis and Therapy Key Players in India
10.3 India Molecular Diagnosis and Therapy Market Size by Type
10.4 India Molecular Diagnosis and Therapy Market Size by Application

11 Central & South America
11.1 Central & South America Molecular Diagnosis and Therapy Market Size (2014-2019)
11.2 Molecular Diagnosis and Therapy Key Players in Central & South America
11.3 Central & South America Molecular Diagnosis and Therapy Market Size by Type
11.4 Central & South America Molecular Diagnosis and Therapy Market Size by Application

12 International Players Profiles
12.1 Abbott Laboratories
12.1.1 Abbott Laboratories Company Details
12.1.2 Company Description and Business Overview
12.1.3 Molecular Diagnosis and Therapy Introduction
12.1.4 Abbott Laboratories Revenue in Molecular Diagnosis and Therapy Business (2014-2019))
12.1.5 Abbott Laboratories Recent Development
12.2 Agilent Technologies
12.2.1 Agilent Technologies Company Details
12.2.2 Company Description and Business Overview
12.2.3 Molecular Diagnosis and Therapy Introduction
12.2.4 Agilent Technologies Revenue in Molecular Diagnosis and Therapy Business (2014-2019)
12.2.5 Agilent Technologies Recent Development
12.3 Becton, Dickinson and Company
12.3.1 Becton, Dickinson and Company Company Details
12.3.2 Company Description and Business Overview
12.3.3 Molecular Diagnosis and Therapy Introduction
12.3.4 Becton, Dickinson and Company Revenue in Molecular Diagnosis and Therapy Business (2014-2019)
12.3.5 Becton, Dickinson and Company Recent Development
12.4 Biomérieux Sa
12.4.1 Biomérieux Sa Company Details
12.4.2 Company Description and Business Overview
12.4.3 Molecular Diagnosis and Therapy Introduction
12.4.4 Biomérieux Sa Revenue in Molecular Diagnosis and Therapy Business (2014-2019)
12.4.5 Biomérieux Sa Recent Development
12.5 Danaher Corporation
12.5.1 Danaher Corporation Company Details
12.5.2 Company Description and Business Overview
12.5.3 Molecular Diagnosis and Therapy Introduction
12.5.4 Danaher Corporation Revenue in Molecular Diagnosis and Therapy Business (2014-2019)
12.5.5 Danaher Corporation Recent Development
12.6 Diasorin
12.6.1 Diasorin Company Details
12.6.2 Company Description and Business Overview
12.6.3 Molecular Diagnosis and Therapy Introduction
12.6.4 Diasorin Revenue in Molecular Diagnosis and Therapy Business (2014-2019)
12.6.5 Diasorin Recent Development
12.7 Grifols
12.7.1 Grifols Company Details
12.7.2 Company Description and Business Overview
12.7.3 Molecular Diagnosis and Therapy Introduction
12.7.4 Grifols Revenue in Molecular Diagnosis and Therapy Business (2014-2019)
12.7.5 Grifols Recent Development
12.8 Hologic
12.8.1 Hologic Company Details
12.8.2 Company Description and Business Overview
12.8.3 Molecular Diagnosis and Therapy Introduction
12.8.4 Hologic Revenue in Molecular Diagnosis and Therapy Business (2014-2019)
12.8.5 Hologic Recent Development
12.9 Illumina
12.9.1 Illumina Company Details
12.9.2 Company Description and Business Overview
12.9.3 Molecular Diagnosis and Therapy Introduction
12.9.4 Illumina Revenue in Molecular Diagnosis and Therapy Business (2014-2019)
12.9.5 Illumina Recent Development
12.10 Qiagen
12.10.1 Qiagen Company Details
12.10.2 Company Description and Business Overview
12.10.3 Molecular Diagnosis and Therapy Introduction
12.10.4 Qiagen Revenue in Molecular Diagnosis and Therapy Business (2014-2019)
12.10.5 Qiagen Recent Development
12.11 Roche Diagnostics
12.12 Siemens AG
12.13 Thermo Fisher Scientific

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

...

【掲載企業】

Abbott Laboratories、Agilent Technologies、Becton, Dickinson and Company、Biomérieux Sa、Danaher Corporation、Diasorin、Grifols、Hologic、Illumina、Qiagen、Roche Diagnostics、Siemens AG、Thermo Fisher Scientific

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 分子診断&治療の世界市場:規模・現状・予測2019-2025(Global Molecular Diagnosis and Therapy Market Size, Status and Forecast 2019-2025)]についてメールでお問い合わせはこちらでお願いします。